| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0064 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0055 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |